Lack of anti-lipoprotein lipase in Behçet's disease;Ausência de anticorpos antilipoproteína lipase na doença de Behçet

Revista Brasileira de Reumatologia

Volumn 49, Issue 6, 2009, Pages 670-676

  De Carvalho, Jozélio Freire ^a,b   Viana, Vilma Santos Trindade ^a,b   Bueno, Cleonice ^a,c   Gonçalves, Célio Roberto ^a   Bonfá, Eloísa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b LIM17 FMUSP

^c LIM17 FMUSP ^*

Author keywords

Atherosclerosis; Autoantibodies; Beh et's disease; Inflammation; Lipoprotein lipase; Lipoproteins; Vasculitis

Indexed keywords

AUTOANTIBODY; C REACTIVE PROTEIN; CHOLESTEROL; ENZYME ANTIBODY; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE ANTIBODY; LOW DENSITY LIPOPROTEIN; PREDNISONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; BEHCET DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; THROMBOSIS;

EID: 75149148649     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0482-50042009000600004     Document Type: Article

References (16)

1. Korn ED. Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J Biol Chem 1955; 215:1-14.
2. de Carvalho JF, Borba EF, Viana VS et al. Antilipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus? Arthritis Rheum 2004; 50:3610-15.
3. Reichlin M, Fesmire J, Quintero-Del-Rio AI, Wolfson-Reichlin M. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus. Arthritis Rheum 2002; 46:2957-63.
4. Kodera M, Hayakawa I, Komura K et al. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations. J Rheumatol 2005; 32:629-36.
5. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990; 335:1078-80.
6. Attman PO, Alaupovic P. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia - relation to renal function and dialysis. Nephron 1991; 57:401-10.
7. Brown WV. Lipoprotein disorders in diabetes mellitus. Med Clin North Am 1994; 78:143-61.
8. Thompson GR, Soutar AK, Spengel FA et al. Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc Natl Acad Sci USA 1981; 78:2591-5.
9. Siedel J, Hägele EO, Zielgenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983; 29:1075-80.
10. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982; 28:2077-80.
11. Warnick GR, Cheung NC, Albers JJ. Comparison of current methods for high density lipoprotein cholesterol quantification. Clin Chem 1979; 25:596-604.
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-96.
14. Zinger H, Sherer Y, Shoenfeld Y. Atherosclerosis in Autoimmune Rheumatic Diseases-Mechanisms and Clinical Findings. Clin Rev Allergy Immunol 2008; 8[Epub ahead of print].
15. Salmon JE, Roman MJ. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 2008; 121:S3-8.
16. Kao AH, Sabatine JM, Manzi S. Update on vascular disease in systemic lupus erythematosus. Curr Opin Rheumatol 2003; 15:519-27